Dr. Ilozumba received her PhD in Epidemiology (Cancer Epidemiology track) from the University of Florida. The goal of Mmadili’s research is to understand the molecular, genetic, and environmental risk factors of cancer etiology and outcomes. Her research also addresses cancer health disparities in racial and ethnic minorities. Dr. Mmadili has conducted several cancer research projects investigating the etiology of several cancer sites including breast, colorectal and prostate cancer and their relationships with risk factors including genetic polymorphisms, obesity (adiposity), environmental exposures, dietary supplements, physical activity, energy intake, gene, and protein expression biomarkers of the mammalian target of rapamycin (mTOR) signaling pathway. Dr. Ilozumba’s current research at Huntsman Cancer Institute focuses on research projects within the ColoCare Study, Total Cancer Care Study, and other consortia (such as FOCUS and MetaboCCC). Specifically, in the ColoCare Study, she will be investigating the associations of molecular, genetic, and environmental risk factors with clinical outcomes such as survival, prognosis, and recurrence as well as cancer health disparities in colorectal cancer patients.